Rare diseases
Investigational molecules
Locations
Back to France868 clinical trials in Rennes, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
FranceStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
FranceStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
FranceStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
FranceStudy of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer
FranceStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
FranceStudy on the Effectiveness and Safety of Bevacizumab, Atezolizumab, and RO7247669 in Patients with Resectable Liver Cancer
FranceStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
FranceStudy on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis
FranceStudy on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery
FranceStudy on the Safety and Effectiveness of TheraSphere, Durvalumab, and Tremelimumab for Patients with Liver Cancer (Hepatocellular Carcinoma)
FranceStudy of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancers, breast cancer, and hematologic malignancies. Studies are evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple research centers are investigating breakthrough treatments for various stages of cancer progression.
Comprehensive research into multiple sclerosis and movement disorders, utilizing advanced imaging techniques and innovative therapeutic approaches.
Studies are focused on improving patient outcomes through targeted interventions and precision medicine approaches.
Investigating new approaches in postoperative care and immunotherapy for critical care patients, with emphasis on patient comfort and infection prevention.
Research aims to enhance recovery outcomes and reduce complications in intensive care settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
